How can self-care companies operating in the UK avoid 'greenwashing' when making environmental claims for their brands? In this episode, HBW Insight speaks to PHD Marketing managing director Jo Stephenson about the new UK Green Claims Code, and how OTC firms can navigate this new guidance on making claims for 'eco-friendly' products. Stephenson also talks about the wider implications of sustainability for the industry, with advice for companies small and large on how to begin taking strategic action against climate change in 2022.
Consumer Health Industry Ideally Placed To Lead And Benefit From Climate Fight
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Navamedic has launched Eroxon in Danish pharmacies giving men in the country OTC access to an ED treatment for the first time.
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”
Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”
A round up of the latest European consumer health exec moves: Hermes hires management board chair; Assosalute elects directors; Moberg appoints ex-Orkla Health CEO.
An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.
Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.
